A Study for HSK39775 in Participants With Solid Tumors

Clinical trial NCT06314373 · RECRUITING

Trial details

NCT number: NCT06314373
Sponsor: Xizang Haisco Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-03-07
Primary completion: 2028-02-01
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.